Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Impacto de Rinitis Alérgica y Urticaria en Calidad de Vida

Impacto de Rinitis Alérgica y Urticaria en Calidad de Vida

Panorama 360 Gaucher Podcast Serisi Makale 2

Panorama 360 Gaucher Podcast Serisi Makale 2

Panorama 360 Gaucher Podcast Serisi Makale 1

Panorama 360 Gaucher Podcast Serisi Makale 1

Panorama 360 Gaucher Podcast Serisi Vaka 2

Panorama 360 Gaucher Podcast Serisi Vaka 2

Panorama 360 Gaucher Podcast Serisi Vaka 1

Panorama 360 Gaucher Podcast Serisi Vaka 1

European Respiratory Society (ERS)/ European Society for Blood and Marrow Transplantation (EBMT) clinical practice guidelines on treatment of pulmonary cGvHD in adults

European Respiratory Society (ERS)/ European Society for Blood and Marrow Transplantation (EBMT) clinical practice guidelines on treatment of pulmonary cGvHD in adults

European Respiratory Society (ERS)/ European Society for Blood and Marrow Transplantation (EBMT) clinical practice guidelines on treatment of pulmonary cGvHD in adults

European Respiratory Society (ERS)/ European Society for Blood and Marrow Transplantation (EBMT) clinical practice guidelines on treatment of pulmonary cGvHD in adults

Lepiej późno niż wcale : dlaczego warto zaszczepić się przeciw grypie w trakcie trwania sezonu zachorowań

Lepiej późno niż wcale : dlaczego warto zaszczepić się przeciw grypie w trakcie trwania sezonu zachorowań

ESC Kongresi 2024 Çıktıları

ESC Kongresi 2024 Çıktıları

Přednáška MUDr. Reichmannové na téma Gaucherova nemoc v klinické praxi

Přednáška MUDr. Reichmannové na téma Gaucherova nemoc v klinické praxi

Cập Nhật Từ Hội Nghị Thường Niên EASD 2024

Cập Nhật Từ Hội Nghị Thường Niên EASD 2024

Personalized approach in T2D is key for success

Personalized approach in T2D is key for success

The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.